Nanoparticulate Radiolabelled Quinolines Detect Amyloid Plaques in Mouse Models of Alzheimer's Disease

  • Roney C
  • Arora V
  • Kulkarni P
  • et al.
N/ACitations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Detecting aggregated amyloid peptides (A β plaques) presents targets for developing biomarkers of Alzheimer's disease (AD). Polymeric n-butyl-2-cyanoacrylate (PBCA) nanoparticles (NPs) were encapsulated with radiolabelled amyloid affinity I 125 -clioquinol (CQ, 5-chloro-7-iodo-8-hydroxyquinoline) as in vivo probes. I 125 -CQ-PBCA NPs crossed the BBB ( 2.3 ± 0.9 ID/g) ( P

Cite

CITATION STYLE

APA

Roney, C. A., Arora, V., Kulkarni, P. V., Antich, P. P., & Bonte, F. J. (2009). Nanoparticulate Radiolabelled Quinolines Detect Amyloid Plaques in Mouse Models of Alzheimer’s Disease. International Journal of Alzheimer’s Disease, 2009, 1–8. https://doi.org/10.4061/2009/481031

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free